Welcome to our dedicated page for Surgery Partners news (Ticker: SGRY), a resource for investors and traders seeking the latest updates and insights on Surgery Partners stock.
Surgery Partners, Inc. (NASDAQ: SGRY) is a healthcare services company headquartered in Brentwood, Tennessee, focused on short-stay and outpatient surgical care. News about Surgery Partners often centers on its performance as a short-stay surgical facility owner and operator, its financing activities, and developments across its network of ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
Investors following SGRY news can expect regular quarterly earnings announcements that discuss revenue growth, same-facility revenues, case volumes, Adjusted EBITDA and liquidity. These releases frequently include guidance ranges for full-year revenues and Adjusted EBITDA, along with commentary from management on operational execution, portfolio performance and the company’s long-term growth approach.
In addition to earnings, Surgery Partners’ news flow includes updates on capital structure and debt financing. Recent items have described the issuance and pricing of 7.250% senior unsecured notes due 2032 through its subsidiary, Surgery Center Holdings, Inc., as well as amendments to its credit agreement that introduce refinancing term loans and revolving credit commitments. These developments are relevant for understanding the company’s funding strategy and leverage profile.
Strategic and partnership news is another key theme. For example, Surgery Partners has announced a joint venture with Baylor Scott & White Health to jointly own a 16-bed hospital in Bryan, Texas, known as The Physicians Centre Hospital. This facility offers a broad range of surgical services, including bariatric, orthopedic, ophthalmologic, gastroenterological, podiatric, spinal and urologic procedures, along with general, plastic and reconstructive surgery, sports medicine, pain management and radiology services.
Governance and leadership updates, such as changes in board roles, executive appointments and resignations, are also disclosed through news releases and Form 8-K filings. For ongoing insight into SGRY, this news page aggregates company-issued announcements, financial updates and material events reported to the SEC.
Surgery Partners (NASDAQ:SGRY) reported third quarter 2025 results for the period ended September 30, 2025. Revenue was $821.5 million, up 6.6% YoY; same-facility revenue rose 6.3%. Adjusted EBITDA was $136.4 million, up 6.1% YoY, while net loss attributable was $22.7 million. Year-to-date revenue was $2,423.7 million, up 7.7%, with YTD Adjusted EBITDA of $369.3 million. Liquidity included $203.4 million cash and $405.9 million revolver capacity. Leverage was ~4.2x net debt/EBITDA and 4.6x consolidated debt/Adj EBITDA. Full-year 2025 guidance: $3.275–3.30 billion revenue and $535–540 million Adjusted EBITDA.
Management noted softer-than-expected volume and payor mix and delayed capital deployment as drivers of a prudent fourth-quarter outlook.
Surgery Partners (NASDAQ:SGRY) will release its third quarter 2025 results before the market opens on Monday, November 10, 2025, followed by a conference call at 8:30 a.m. ET.
Live dial-in numbers: 1-877-451-6152 (domestic) and 1-201-389-0879 (international). A replay will be available three hours after the call until November 24, 2025 at 1-844-512-2921 (domestic) and 1-412-317-6671 (international). Passcode for live and replay: 13756022. A simultaneous webcast and replay will be available on the company Investor Relations website at www.surgerypartners.com.
Surgery Partners (NASDAQ:SGRY) reported strong Q2 2025 financial results, with revenue increasing 8.4% to $826.2 million and Adjusted EBITDA growing 9.0% to $129.0 million. Same-facility revenues rose 5.1%, driven by a 3.4% increase in cases and 1.6% growth in revenue per case.
The company reaffirmed its full-year 2025 guidance, projecting revenue between $3.30-3.45 billion and Adjusted EBITDA of $555-565 million. Surgery Partners maintained strong liquidity with $250.1 million in cash and $394.9 million available under its revolving credit facility, while operating cash flow was $81.3 million for Q2 2025.
Surgery Partners (NASDAQ:SGRY), a leading short-stay surgical facility operator, has scheduled its second quarter 2025 earnings release for Tuesday, August 5, 2025, before market open. The company will host a conference call at 8:30 a.m. Eastern Time to discuss the results.
Investors can access the call via phone (1-844-826-3033 domestic, 1-412-317-5185 international) or through a simultaneous webcast on the Investor Relations section of Surgery Partners' website. A replay will be available for two weeks until August 19, 2025, using passcode 10201328.
Surgery Partners (NASDAQ:SGRY) has scheduled its first quarter 2025 earnings release and conference call. The company will release Q1 2025 results before market open on Monday, May 12, 2025, followed by a conference call at 8:30 a.m. Eastern Time.
Investors can access the live call via phone at 1-877-451-6152 (domestic) or 1-201-389-0879 (international). A replay will be available for two weeks until May 26, 2025, accessible at 1-844-512-2921 (domestic) or 1-412-317-6671 (international) using passcode 13752904.
A simultaneous webcast will be available on the Investor Relations section of Surgery Partners' website at www.surgerypartners.com, where the replay will also be accessible.
Surgery Partners (NASDAQ:SGRY) reported strong financial results for Q4 and full year 2024. Revenue increased 17.5% to $864.4M in Q4 and 13.5% to $3.1B for the full year. Same-facility revenues grew 5.6% in Q4 and 8.0% for 2024.
The company posted Q4 Adjusted EBITDA of $163.8M, up 15.1%, and full-year Adjusted EBITDA of $508.2M, a 16.0% increase. However, net losses were $108.5M for Q4 and $168.1M for 2024.
For 2025, Surgery Partners projects revenue between $3.30B-$3.45B and Adjusted EBITDA of $555M-$565M. The company maintains strong liquidity with $269.5M cash and $501.5M in credit facility availability. Operating cash flows improved to $111.4M in Q4 2024 from $62.6M in Q4 2023.
Surgery Partners (NASDAQ:SGRY), a leading short-stay surgical facility operator, has scheduled its fourth quarter 2024 earnings release for Monday, March 3, 2025, before market open. The company will host a conference call at 8:30 a.m. Eastern Time on the same day.
Participants can access the call via phone using 1-877-451-6152 (domestic) or 1-201-389-0879 (international). A replay will be available for two weeks until March 17, 2025, accessible at 1-844-512-2921 (domestic) or 1-412-317-6671 (international) using passcode 13751533. A simultaneous webcast will be available on the Investor Relations section of the company's website.
Surgery Partners (NASDAQ: SGRY) has received a non-binding acquisition proposal from Bain Capital Private Equity to purchase all outstanding shares not already owned by Bain Capital for $25.75 per share in cash. Bain Capital and its affiliates currently own approximately 39% of the Company's outstanding common stock.
A Special Committee of independent directors will evaluate the proposal with independent financial and legal advisors. The proposed transaction would require approval from both a majority of non-Bain Capital shareholders and a Special Committee of independent directors.
The company emphasizes that no decisions have been made regarding the proposal, and there is no guarantee that a definitive offer will be made or that any transaction will be completed.